A technique of total intravenous anaesthesia using etomidate by bolus intravenous (IV) injection for induction and by continuous intravenous infusion for maintenance of anaesthesia, with supplementary intravenous fentanyl analgesia, is described. Muscle relaxation was provided by competitive neuromuscular blockade, allowing controlled ventilation of the lungs with oxygenenriched air. Arterial blood pressure, heart rate and rhythm remained stable throughout the procedure. Few complications were encountered of which the most significant was a 13 % incidence of nausea and/or vomiting. Pain on injection, abnormal muscular movements on induction, and post operative venous sequelae were uncommon. Patients were easily rousable shortly after termination of drug infusion. The technique proved acceptable to the patient, surgeon and experienced anaesthetist and, thereby, would appear to offer a reasonable alternative to the more conventional inhalational anaesthetic technique.
The use of anaesthetic gases and vapours carries a theoretical risk to both patients and theatre personnel. l ,2 Development of a purely intravenous technique, in combination with muscle relaxation and ventilation of the lungs with an air/oxygen mixture, could represent a major breakthrough towards the elimination of operating theatre pollution. 3 Etomidate, an imidazole derivative, is a potent, water-soluble, intravenous anaesthetic agent, suitable for both the induction and maintenance of hypnosis during balanced anaesthesia. 4 ,5 Fentanyl produces good analgesia and reflex suppression, without significant cardiovascular side effects, when compared with equivalent doses of other opiates in man. 6 The purpose of this study was to assess an anaesthetic technique employing intravenous etomidate by bolus injection and then continuous infusion, with intermittent fentanyl supplementation, muscle relaxation and controlled pulmonary ventilation with an air/oxygen mixture for major abdominal surgery.
PATIENTS AND METHODS
Forty female patients aged between 21 and 69 years, scheduled for major gynaecological surgery, were studied. Informed patient consent was obtained at the preoperative visit. The investigation was approved by the Ethical and Standards Committee of the Board of the Faculty of Medicine, University of Natal. All patients were rated as either ASA I or 11. Premedication was with oral lorazepam 2-2.5 mg given at 2200 hours the evening prior to surgery. A similar oral dose was administered 120 minutes preoperatively. A history of previous anaesthetics was also noted preoperatively.
The patient mean age was 41 years (SE ± 2.02), their average body weight 60.5 kg (SE ± 1.82).
On arrival in the operating theatre, patients were given a two digit number between 10-100 to remember. An intravenous cannula was inserted into a forearm vein and an infusion of balanced salt solution (plasmalyte L *) started. ECG electrodes were positioned on the patient's chest, attached to an ECG monitor (Mennen-Greatbatch Portoscope). ** In the opposite arm, another IV intravenous line was set up with a 200 ml solution of normal saline, containing 125 mg etomidate, in an alcohol base for continuous infusion. This drip was not used for any other medication. The patients were then given an intravenous injection of droperidol 5 mg followed by 100 I1g fentanyl. Glycopyrrolate 0.2 mg was also given intravenously, followed by 2 mg of alcuronium chloride. All these drugs were injected through the original intravenous cannula intended for fluid infusion.
The patient breathed oxygen by mask, delivered via a Mapleson A non-rebreathing anaesthetic system, for five minutes. Anaesthesia was induced with a bolus intravenous injection of etomidate (Hypnomidate) 0.3 mg/kg given over 45 seconds. (Hypnomidate is dissolved in a propyleneglycol and water base.) The dose has been recommended by the manufacturer after consideration of results obtained from previous studies. 7 ,8 Etomidate by intravenous infusion was then commenced, controlling the flow rate with an in line Dial-a-flow* (infusion controller) to provide a dose of etomidate of 0.02 mg/kg/min. ** Endotracheal intubation, with a cuffed Portex tube, followed lllJection of suxamethonium 1 mg/kg intravenously. air, achieving a delivered Fj02 of 0.4 as monitored with an Ohio 600 oxygen analyser. A Beaver valve was placed just proximal to the catheter mount, the system thus functioning in a non-rebreathing mode and allowing minute ventilation to be monitored intermittently with a Wright respirometer and adjusted to 120 mllkg/min. Further muscle relaxation was provided by the intravenous injection of alcuronium chloride, 0.2-0.3 mg/kg. Inhalational agents and gases were specifically avoided. Particular attention was paid to complaints of pain on injection at induction and observation of abnormal muscular movements during the initiation of anaesthesia. Prior to surgical incision, analgesia was augmented with an additional supplementary intravenous injection of fentanyl 200 I1g. Further increments of 50 I1g of fentanyl were given according to clinical evaluation of the patient's response to surgery, e.g. sweating, lacrimation and increase in pulse rate and/or blood pressure, both of which were recorded every five minutes throughout the operation. The ECG pattern was displayed continuously on the monitor screen.
The surgeon was asked to comment at the end of the procedure on the operating conditions provided by the anaesthetic technique, stating it to be good, satisfactory or poor.
In the immediate recovery phase-time to waking and to the patient first being able to communicate, were noted. All patients were given oxygen via a Ventimask. The recovery room staff were requested to note evidence of respiratory depression, abnormal movements and the occurrence of nausea or vomiting during emergence. Each patient was seen again within 24 hours of operation, and questioned regarding pain on injection, dreaming, factual recall for both the given number and perioperative events, and willingness to accept a similar anaesthetic again. Evidence of undesirable sequelae at the site of both intravenous infusion and injection of etomidate was noted.
RESULTS
The mean duration of anaesthesia was 87 minutes (SE ± 11.36). The mean dose of etomidate for anaesthetic induction was 16.7 mg (SE ± 0.53) followed by a mean infusion Anaesthesia and Intensive Care, Vol. IX, No. 2, May, 1981 dose of etomidate for anaesthetic maintenance of 73.5 mg (SE±5.50). The mean supplementary dose of fentanyl required was 3751lgm (SE ± 20).
Period of Induction:
At induction all patients were normotensive. Induction was deemed satisfactory by the anaesth~tists in all cases. Four patients (10010) complamed of mild pain on injection of the induction dose of etomidate. In no case, however, was pain severe enough to necessitate curtailment of the injection. No patient exhibited abnormal movements and unconsciousness was achieved within 45 seconds in all subjects. Blood pressure, heart rate and rhythm remained stable throughout the induction period.
Intra-operative period:
Systolic blood pressure rose above 150 mmHg in four patients during anaesthesia. These episodes were treated by the intravenous injection of fentanyl 50 Ilg. The total dose of fentanyl given to these subjects was in excess of the overall mean dose, averaging 550 Ilg for the four anaesthetics. However, these patients took no longer to waken nor did they exhibit evidence of postoperative respiratory depression. (Respiration rate < 8 breaths/min.) Intra-operative bleeding was Judged excessive in one of the four subjects mentioned above. This patient also complained afterwards of awareness during the operative procedure and deemed the anaesthetic unsatisfactory. The remaining 39 subjects found the technique to be acceptable and would have accepted the same anaesthetic if offered again. Twenty-six patients had had previous anaesthetics.
Cardiovascular trends were recorded in all cases throughout the anaesthetic from the period of induction to adequate' reversal of nondepolarising muscle relaxant and endotracheal extubation. A paired t-test was performed on systolic Blood Pressure and heart ~ate. ~he mean systolic Blood Pressure prior to mductlOn of anaesthesia was 114 Hg (Sem 2.68) and ranged from 116 mm Hg (SE 2.41) to 127 mm Hg (SE 3.47). The mean basal heart rate was ~1 beats/min (SE 2.08) and ranged from 85/mm (SE 2.00) to 94/min (SE 4.65). No Anaesthesia and Intensive Care, Vo!. IX, No. 2, May, 1981 significant change in either mean systolic blood pressure or heart rate were noted during this period. Operating conditions were found to be good in all but two cases where the surgeons noted excessive bleeding.
Conditions during emergence
All patients were calm and sleepy during emergence and all but one were rousable. The latter was the first patient studied and the longer recovery could be attributed to inexperience in the timing of discontinuing the etomidate infusion. The mean times to waking and patient communication were 16.6 min (SE±3.30, range 1-125 min) and 30.35 mins (SE±4.51, range 2-145 mins) respectively. No patient was delirious or appeared to be hallucinating during the recovery phase. All had an uneventful stay in the recovery room and were transferred to their respective wards once they could communicate satisfactorily. Respiratory depression necessitating reversal of the fentanyl, in the recovery room, was not observed.
Post anaesthetic sequelae
At the postoperative interview, one patient reported pleasant dreams and one other unpleasant dreams which did not deter her from accepting a similar technique again. Four patients (10%) complained of pain on injection of etomidate. Five patients (13%) complained of postoperative nausea and/or vomiting. Ten per cent (four patients) had evidence of venous thrombosis following injection in either arm. Only three patients found the anaesthetic to be problematic, one complaining of pain on injection, another of postoperative pain and a third of awareness during surgery.
Factual recall
Ten patients (25%) of the 40 patients studied remembered the number given to them prior to induction. Twenty-seven patients (67%) did not remember the mask and three patients exhibited anterograde amnesia, and could only remember leaving the ward. One patient claimed to have been aware during the operation.
DISCUSSION
Development of an anaesthetic technique relying upon total intravenous narcosis would seem an important preventative measure towards eliminating the possible short term and long term hazards to both patients and theatre personnel posed by spillage of noxious anaesthetic gases and vapours. I ,2 Agents used for total intravenous anaesthesia must be relatively non-toxic and non-cumulative. Etomidate would seem to meet these requirements closely.9,1O The drug is rapidly biotransformed in the liver to pharmacologically inactive compounds. 9,10, II Fentanyl is a rapid acting narcotic analgesic with minimal cumulative properties, although delayed respiratory depression has occurred occasionally after fentanyl administration. 13 The technique used in this study provided adequate anaesthesia and satisfactory surgical conditions in the majority of patients. The principal complications were nausea and vomiting (13%), an incidence which was, however, much lower than that found in a previous study (30%), where no specific antiemetic was used. 14 A refinement of our technique using supplementary intravenous droperidol at termination of anaesthesia might reduce the incidence of nausea and vomiting further.
The reported incidence of pain at the site of injection with etomidate has been high. 4 In this study, pain on injection of etomidate into a peripheral vein was noted in four patients, but was unacceptable in only one. This may be accounted for by the prior use of fentanyl and also the fast rate of injection of etomidate. 15 A number of patients exhibited a degree of anterograde amnesia, the majority not being able to remember the preoxygenation period. Factual recall was poor for the two-digit number, only 33070 of patients being able to remember the number given to them prior to anaesthetic induction. These findings we feel were probably related to the use of Lorazepam premedication. There was a comparatively low incidence of venous sequelae noted at the etomidate injection sites. This can be attributed mainly to the use of the alcohol-based etomidate infusion.
In this study, no abnormal muscular movements were observed, probably because of the premedication. 16 Furthermore, no restlessness was noted during the emergence period when all patients were observed to be calm. Only female patients requiring lower abdominal surgery were selected, with a similar premedication, so as to make comparison of postoperative drowsiness, nausea and vomiting easier.
One patient complained of awareness during the operation although she was noted to be calm and sleepy during the recovery phase. She had not had a previous anaesthetic and during her postoperative recovery period required a considerable amount of analgesia. Careful questioning at the postoperative visit revealed the patient to be an unreliable historian in that she could not recall any factual events related to the operation at the post-anaesthetic interview even when prompted.
The authors' experience suggests that the etomidate infusion can be discontinued ten minutes prior to the last surgical stitch being placed, thus hastening awakening in the recovery phase. This anaesthetic technique does, however, require proper postoperative observation of vital parameters and is not suitable for outpatient or day hospital surgery.
The technique of total intravenous anaesthesia must, like any other anaesthetic be closely supervised with the specific object of avoiding awareness, i.e. changes in heart rate, BP, pupil size, lacrimation and evidence of sweating.
The infusion of etomidate was at a fixed rate. We did not change the infusion rates during the anaesthetic to ascertain the possible effects on the cardiovascular system. Nor did we attempt to define a standard anaesthetic dose relative to the surgical response, i.e. an equivalent infusion rate of etomidate to the minimum alveolar concentration of a gaseous or volatile anaesthetic. This latter is a study on its own.
In summary, we have described a technique of total intravenous anaesthesia using an agent which is potentially safe, noncumulative and easy to administer. The method offers satisfactory surgical conditions and obviates the problems of theatre pollution, whilst ensuring adequate patient anaesthesia. Further trial using this technique for other types of surgery would seem indicated.
supply of etomidate used in this study. Dial-aflow was kindly donated by Hospital Products, Durban.
